160 related articles for article (PubMed ID: 31075266)
21. Triptonide inhibits lung cancer cell tumorigenicity by selectively attenuating the Shh-Gli1 signaling pathway.
Zhang M; Tan S; Yu D; Zhao Z; Zhang B; Zhang P; Lv C; Zhou Q; Cao Z
Toxicol Appl Pharmacol; 2019 Feb; 365():1-8. PubMed ID: 30610878
[TBL] [Abstract][Full Text] [Related]
22. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia.
Tanno M; Bassi R; Gorog DA; Saurin AT; Jiang J; Heads RJ; Martin JL; Davis RJ; Flavell RA; Marber MS
Circ Res; 2003 Aug; 93(3):254-61. PubMed ID: 12829618
[TBL] [Abstract][Full Text] [Related]
23. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
24. Dehydroeffusol inhibits gastric cancer cell growth and tumorigenicity by selectively inducing tumor-suppressive endoplasmic reticulum stress and a moderate apoptosis.
Zhang B; Han H; Fu S; Yang P; Gu Z; Zhou Q; Cao Z
Biochem Pharmacol; 2016 Mar; 104():8-18. PubMed ID: 26774454
[TBL] [Abstract][Full Text] [Related]
25. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.
Hickson JA; Huo D; Vander Griend DJ; Lin A; Rinker-Schaeffer CW; Yamada SD
Cancer Res; 2006 Feb; 66(4):2264-70. PubMed ID: 16489030
[TBL] [Abstract][Full Text] [Related]
26. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
Chun J; Kim YS
Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
[TBL] [Abstract][Full Text] [Related]
27. A Ferulic Acid Derivative FXS-3 Inhibits Proliferation and Metastasis of Human Lung Cancer A549 Cells via Positive JNK Signaling Pathway and Negative ERK/p38, AKT/mTOR and MEK/ERK Signaling Pathways.
Yue SJ; Zhang PX; Zhu Y; Li NG; Chen YY; Li JJ; Zhang S; Jin RY; Yan H; Shi XQ; Tang YP; Duan JA
Molecules; 2019 Jun; 24(11):. PubMed ID: 31181779
[TBL] [Abstract][Full Text] [Related]
28. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK.
Nakano A; Baines CP; Kim SO; Pelech SL; Downey JM; Cohen MV; Critz SD
Circ Res; 2000 Feb; 86(2):144-51. PubMed ID: 10666409
[TBL] [Abstract][Full Text] [Related]
29. Transcription activation of myostatin by trichostatin A in differentiated C2C12 myocytes via ASK1-MKK3/4/6-JNK and p38 mitogen-activated protein kinase pathways.
Han DS; Huang HP; Wang TG; Hung MY; Ke JY; Chang KT; Chang HY; Ho YP; Hsieh WY; Yang WS
J Cell Biochem; 2010 Oct; 111(3):564-73. PubMed ID: 20568119
[TBL] [Abstract][Full Text] [Related]
30. Cell-type-specific activation of p38 protein kinase cascades by the novel tumor promoter palytoxin.
Li S; Wattenberg EV
Toxicol Appl Pharmacol; 1999 Oct; 160(2):109-19. PubMed ID: 10527909
[TBL] [Abstract][Full Text] [Related]
31. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells.
Stone AA; Chambers TC
Exp Cell Res; 2000 Jan; 254(1):110-9. PubMed ID: 10623471
[TBL] [Abstract][Full Text] [Related]
32. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
Park HJ; Kim BC; Kim SJ; Choi KS
Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621
[TBL] [Abstract][Full Text] [Related]
33. Activation and role of mitogen-activated protein kinases in deoxycholic acid-induced apoptosis.
Qiao D; Stratagouleas ED; Martinez JD
Carcinogenesis; 2001 Jan; 22(1):35-41. PubMed ID: 11159738
[TBL] [Abstract][Full Text] [Related]
34. Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils.
Nick JA; Avdi NJ; Young SK; Lehman LA; McDonald PP; Frasch SC; Billstrom MA; Henson PM; Johnson GL; Worthen GS
J Clin Invest; 1999 Mar; 103(6):851-8. PubMed ID: 10079106
[TBL] [Abstract][Full Text] [Related]
35. Ginkgetin inhibits growth of breast carcinoma via regulating MAPKs pathway.
Cao J; Tong C; Liu Y; Wang J; Ni X; Xiong MM
Biomed Pharmacother; 2017 Dec; 96():450-458. PubMed ID: 29031204
[TBL] [Abstract][Full Text] [Related]
36. c-Abl-induced apoptosis, but not cell cycle arrest, requires mitogen-activated protein kinase kinase 6 activation.
Cong F; Goff SP
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13819-24. PubMed ID: 10570156
[TBL] [Abstract][Full Text] [Related]
37. Cardioprotective 3',4'-dihydroxyflavonol attenuation of JNK and p38(MAPK) signalling involves CaMKII inhibition.
Lim NR; Thomas CJ; Silva LS; Yeap YY; Yap S; Bell JR; Delbridge LM; Bogoyevitch MA; Woodman OL; Williams SJ; May CN; Ng DC
Biochem J; 2013 Dec; 456(2):149-61. PubMed ID: 24032640
[TBL] [Abstract][Full Text] [Related]
38. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
39. The activation of ERK1/2 and p38 mitogen-activated protein kinases is dynamically regulated in the developing rat visual system.
Oliveira CS; Rigon AP; Leal RB; Rossi FM
Int J Dev Neurosci; 2008; 26(3-4):355-62. PubMed ID: 18280691
[TBL] [Abstract][Full Text] [Related]
40. Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38.
Johnson RA; Huong SM; Huang ES
J Virol; 2000 Feb; 74(3):1158-67. PubMed ID: 10627526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
